Rheumatoid Arthritis — Safety and Preliminary Efficacy of MOR103 in Patients With Active Rheumatoid Arthritis
Citation(s)
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Preliminary Clinical Activity and Immunogenicity of Multiple Doses of MOR103 Administered Intravenously to Patients With Active Rheumatoid Arthritis